title: Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition--The Dream of Translational Medicine.
authors.affiliation: *CANSEARCH Research Laboratory, Department of Pediatrics, Geneva, Switzerland†Department of Cardiology, SRM Medical College Hospital and Research Centre, Kancheepuram, India.
authors.forename: Chakradhara Rao S
authors.initials: CR
authors.lastname: Uppugunduri
authors.forename: Melvin
authors.initials: M
authors.lastname: George
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D000091362:PCSK9 Inhibitors; D000071449:Proprotein Convertase 9 / Q000378:metabolism; D043484:Proprotein Convertases / Q000037:antagonists & inhibitors / Q000378:metabolism; D057170:Translational Research, Biomedical / Q000379:methods* / Q000639:trends
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000091362:PCSK9 Inhibitors; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; C571059:alirocumab